ArticleVaccines2025
Understanding the Implications of Delaying Seasonal Influenza Vaccine Recommendations: An Industry Perspective.
Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple studies have assessed the potential for improvement for genetic and antigenic match of influenza vaccines to circulating viruses by altering the timing of vaccine strain decisions. The advent of new technologies for vaccination has generated global discussion around moving the seasonal influenza strain recommendations closer to the start of the vaccination period. The window between influenza vaccine strain recommendations and the availability of vaccine supply for immunization comprises sequential processes required to produce vaccine components, reagents for manufacture and release, and regulatory approvals. This commentary examines one company's perspective on requirements for enabling manufacture and release of seasonal influenza vaccine in more detail, describes preparations to reduce risk, and highlights the potential impact on vaccine supply for all platforms (egg, cell, mRNA) when strain decisions are issued closer to the desired vaccination timing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.